Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revision Previous revision
Next revision
Previous revision
publications [2025/12/22 14:51]
ramirez [2025]
publications [2026/01/27 10:45] (current)
ramirez [2026]
Line 1: Line 1:
 ====== Publications ====== ====== Publications ======
 +
 +===== 2026  =====
 +Martins ER, Forofontov M, Mota Freitas J, [[people:​jmelocristino|Melo-Cristino J]], [[people:​ramirez|Ramirez M]]. 2026. <fc #​0000FF>​Two //​Streptococcus agalactiae//​ ST283 invasive infections in Portugal raise the possibility of the emergence of this unusual lineage in Europe</​fc>​. Front Microbiol 16. //In press//
  
 ===== 2025  ===== ===== 2025  =====
Line 13: Line 16:
  
 Lenglart L, Özmen I, Aguilera-Alonso D, Blazquez-Gamero D, Boeddha NP, Buddingh EP, Buonsenso D, Calvo C, Castagnoli R, Daina M, Dourdouna M-M, Emonts M, Ezinwoke C, Gouveia C, Vas DG, Hol J, Holm M, Kahlert CR, Kohlmaier B, Ludwikowska K, Marseglia GL, McArdle A, McGalliard R, Michos A, Nagle A, Niederer-Loher A, Nygaard U, Oostenbrink R, Srovin TP, Roisin S, Saavedra-Lozano J, Shan A, Thors VS, Strenger V, Syngelou A, Tilmanne A, Tokarczyk M, Tsilifis C, Tsolia M, Tulling A, van Kempen E, Van Veen M, Vincek K, Von Both U, Zavadska D, Zaman M, Nijman RG, Ouldali N, Borensztajn D, Lenglart L, Özmen I, Aguilera-Alonso D, Blazquez-Gamero D, Boeddha NP, Buddingh EP, Buonsenso D, Calvo C, Castagnoli R, Daina M, Dourdouna M-M, Emonts M, Ezinwoke C, Gouveia C, Vas DG, Hol J, Holm M, Kahlert CR, Kohlmaier B, Ludwikowska K, Marseglia GL, McArdle A, McGalliard R, Michos A, Nagle A, Niederer-Loher A, Nygaard U, Oostenbrink R, Srovin TP, Roisin S, Saavedra-Lozano J, Shan A, Thors VS, Strenger V, Syngelou A, Tilmanne A, Tokarczyk M, Tsilifis C, Tsolia M, Tulling A, van Kempen E, Van Veen M, Vincek K, Von Both U, Zavadska D, Zaman M, Nijman RG, Ouldali N, Borensztajn D, Dekkers F, Giske C, Hawkins R, Hertting O, Kolnik M, Carrol E, Lewis-Burke N, Pokorn M, Raghoenath P, Rhedin S, Rozemeijer W, Seme K, Syrimi N, Tatsi E-B, Velimirovic I, Wilfing S, Till H, Ramirez M, Friães A. 2025. <fc #​0000FF>​Paediatric invasive group A streptococcal infections and associations with viral infections in 15 European countries after lifting non-pharmaceutical interventions against SARS-CoV-2: an interrupted time-series analysis</​fc>​. Lancet Reg Health - Eur 59:101497. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​41170145/​|(PMID:​ 41170145)]]. Lenglart L, Özmen I, Aguilera-Alonso D, Blazquez-Gamero D, Boeddha NP, Buddingh EP, Buonsenso D, Calvo C, Castagnoli R, Daina M, Dourdouna M-M, Emonts M, Ezinwoke C, Gouveia C, Vas DG, Hol J, Holm M, Kahlert CR, Kohlmaier B, Ludwikowska K, Marseglia GL, McArdle A, McGalliard R, Michos A, Nagle A, Niederer-Loher A, Nygaard U, Oostenbrink R, Srovin TP, Roisin S, Saavedra-Lozano J, Shan A, Thors VS, Strenger V, Syngelou A, Tilmanne A, Tokarczyk M, Tsilifis C, Tsolia M, Tulling A, van Kempen E, Van Veen M, Vincek K, Von Both U, Zavadska D, Zaman M, Nijman RG, Ouldali N, Borensztajn D, Lenglart L, Özmen I, Aguilera-Alonso D, Blazquez-Gamero D, Boeddha NP, Buddingh EP, Buonsenso D, Calvo C, Castagnoli R, Daina M, Dourdouna M-M, Emonts M, Ezinwoke C, Gouveia C, Vas DG, Hol J, Holm M, Kahlert CR, Kohlmaier B, Ludwikowska K, Marseglia GL, McArdle A, McGalliard R, Michos A, Nagle A, Niederer-Loher A, Nygaard U, Oostenbrink R, Srovin TP, Roisin S, Saavedra-Lozano J, Shan A, Thors VS, Strenger V, Syngelou A, Tilmanne A, Tokarczyk M, Tsilifis C, Tsolia M, Tulling A, van Kempen E, Van Veen M, Vincek K, Von Both U, Zavadska D, Zaman M, Nijman RG, Ouldali N, Borensztajn D, Dekkers F, Giske C, Hawkins R, Hertting O, Kolnik M, Carrol E, Lewis-Burke N, Pokorn M, Raghoenath P, Rhedin S, Rozemeijer W, Seme K, Syrimi N, Tatsi E-B, Velimirovic I, Wilfing S, Till H, Ramirez M, Friães A. 2025. <fc #​0000FF>​Paediatric invasive group A streptococcal infections and associations with viral infections in 15 European countries after lifting non-pharmaceutical interventions against SARS-CoV-2: an interrupted time-series analysis</​fc>​. Lancet Reg Health - Eur 59:101497. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​41170145/​|(PMID:​ 41170145)]].
 +
 +Hänscheid T, Mahomed S, Oliveira L, Pereira DS, Grobusch MP. 2025. <fc #​0000FF>​Fluorescent acid-fast stains for diagnosing mycobacteria and beyond: back to the future?</​fc>​ Lancet, Microbe 101233 [[https://​www.ncbi.nlm.nih.gov/​pubmed/​41135557/​|(PMID:​ 41135557)]].
  
 [[people:​afriaes|Friães A]], Mamede R, Santos B, Marrão G, [[people:​jmelocristino|Melo-Cristino J]], [[people:​ramirez|Ramirez M]]. 2025. <fc #​0000FF>​Increase of macrolide resistance among //​Streptococcus pyogenes// pharyngitis driven by a //​mef//​(A)-//​msr//​(D)///​emm//​2-ST55 lineage in Portugal (2014-2019)</​fc>​. Antimicrob Agents Chemother 69:​e0096825. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​41071123/​|(PMID:​ 41071123)]] [[people:​afriaes|Friães A]], Mamede R, Santos B, Marrão G, [[people:​jmelocristino|Melo-Cristino J]], [[people:​ramirez|Ramirez M]]. 2025. <fc #​0000FF>​Increase of macrolide resistance among //​Streptococcus pyogenes// pharyngitis driven by a //​mef//​(A)-//​msr//​(D)///​emm//​2-ST55 lineage in Portugal (2014-2019)</​fc>​. Antimicrob Agents Chemother 69:​e0096825. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​41071123/​|(PMID:​ 41071123)]]
 +
 +Piontkivska D, Jorge JMP, Mil-Homens D, Martins TM, Crespo P, Morales DP, Carvalho D, [[people:​jmelocristino|Melo-Cristino J]], Sá-Leão R, Goldman GH, Silva Pereira C. 2025. <fc #​0000FF>​Hidden allies: decoding the core endohyphal bacteriome of //​Aspergillus fumigatus//</​fc>​. Environ Microbiol Rep 17:e70153. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​40831189/​|(PMID:​ 40831189)]]
  
 Hänscheid T, Carrasco J, Grobusch MP. 2025. Re: comparing large language models for antibiotic prescribing in different clinical scenarios: which performs better? Clin Microbiol Infect 31:​2102–2103 [[https://​www.ncbi.nlm.nih.gov/​pubmed/​40812548/​|(PMID:​ 40812548)]] Hänscheid T, Carrasco J, Grobusch MP. 2025. Re: comparing large language models for antibiotic prescribing in different clinical scenarios: which performs better? Clin Microbiol Infect 31:​2102–2103 [[https://​www.ncbi.nlm.nih.gov/​pubmed/​40812548/​|(PMID:​ 40812548)]]
  
 Firmino M de O, Forofontov M, Soares R, Louro RO, Alberto J. Martín-Rodríguez,​ [[people:​ramirez|Ramirez M]], Paquete CM. 2025. <fc #​0000FF>​Polyphasic discrimination of //​Shewanella seohaensis//​ from closely related species and a whole-genome multilocus (wgMLST) scheme for the evaluation of diversity within this //​Shewanella//​ clade</​fc>​. Appl Environ Microbiol 91:​e0118925. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​40801780/​|(PMID:​ 40801780)]] Firmino M de O, Forofontov M, Soares R, Louro RO, Alberto J. Martín-Rodríguez,​ [[people:​ramirez|Ramirez M]], Paquete CM. 2025. <fc #​0000FF>​Polyphasic discrimination of //​Shewanella seohaensis//​ from closely related species and a whole-genome multilocus (wgMLST) scheme for the evaluation of diversity within this //​Shewanella//​ clade</​fc>​. Appl Environ Microbiol 91:​e0118925. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​40801780/​|(PMID:​ 40801780)]]
 +
 +Elias R, Phelan JE, Lito L, Caneiras C, Marques C, Pinto M, Cavaco-Silva P, Ferreira H, Pomba C, Da Silva GJ, Saavedra MJ, Coelho R, Lourinho R, Gonçalves L, Hinthong W, Rosa MJ, [[people:​jmelocristino|Melo-Cristino J]], Campino S, Portugal I, Duarte A, Clark TG, Perdigão J. 2025. <fc #​0000FF>​Genome-wide analysis and longitudinal study of //​Klebsiella pneumoniae//​ in Portugal: tracing the evolution and spread of carbapenem resistance</​fc>​. Int J Antimicrob Agents 66:107583. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​40750043/​|(PMID:​ 40750043)]]
 +
 +Schnyder JL, Bache BE, Hoogakker M, Van De Ruit M, Zonneveld R, Hermans SM, Stijnis C, Van Vugt M, Hänscheid T, Van Hest RM, Goorhuis A, de Jong HK, Grobusch MP. 2025. <fc #​0000FF>​Malaria recrudescence after artemether-lumefantrine treatment in travellers- a hospital-based observational study and literature review</​fc>​. Trop Dis, Travel Med Vaccines 11:19. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​40619429/​|(PMID:​ 40619429)]]
  
 Boattini M, Aceti A, Bastos P, Mavromanolaki VE, Maraki S, Spiliopoulou A, Kakouris V, Kalchev Y, Budimir A, Bedenić B, Rubic Z, Licker M, Musuroi C, Juhász E, Kristóf K, Pirs M, Velimirovic I, Berktold M, Liptáková A, Krajčíková A, Drevinek P, Gryndlerova A, Brzychczy-Wloch M, Olechowska-Jarząb A, Bielec F, Brauncajs M, Podsiadly E, Nurzyńska G, Zalas-Więcek P, Michalska A, Riesbeck K, Andersson H-S, Tønjum T, Berild JC, Leegaard TM, Rasmussen AN, Schønning K, Glöckner S, Rödel J, Badr MT, Häcker GA, Stark D, Hamprecht A, Dudakova A, Jantsch J, Mancini S, Quiblier C, Jacot D, Greub G, Ferniani T, Ambretti S, Calvo M, Stefani S, Schade R, Yusuf E, van Kleef-van Koeveringe S, Vandamme S, Verroken A, Rodriguez-Villalobos H, Duigou F, Corvec S, Floch P, Massip C, Chainier D, Barraud O, Louissaint M-B, Mizrahi A, Ali S, Doyle M, Egan C, McNicholas S, Colomina-Rodriguez J, Torres I, Gillaranz Luengo R, Larrosa Escartín MN, Viñado Perez MB, Halperin AV, Fuente García S, Cantón R, Seruca M, Santos Mendes V, Carvalho D, Cavallo R, [[people:​jmelocristino|Melo-Cristino J]], Costa C, Bianco G. 2025. <fc #​0000FF>​A european survey on anaerobes from paediatric blood cultures: a comparative analysis with adults</​fc>​. Eur J Clin Microbiol Infect Dis 44:​2207–2217. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​40537731/​|(PMID:​ 40537731)]] Boattini M, Aceti A, Bastos P, Mavromanolaki VE, Maraki S, Spiliopoulou A, Kakouris V, Kalchev Y, Budimir A, Bedenić B, Rubic Z, Licker M, Musuroi C, Juhász E, Kristóf K, Pirs M, Velimirovic I, Berktold M, Liptáková A, Krajčíková A, Drevinek P, Gryndlerova A, Brzychczy-Wloch M, Olechowska-Jarząb A, Bielec F, Brauncajs M, Podsiadly E, Nurzyńska G, Zalas-Więcek P, Michalska A, Riesbeck K, Andersson H-S, Tønjum T, Berild JC, Leegaard TM, Rasmussen AN, Schønning K, Glöckner S, Rödel J, Badr MT, Häcker GA, Stark D, Hamprecht A, Dudakova A, Jantsch J, Mancini S, Quiblier C, Jacot D, Greub G, Ferniani T, Ambretti S, Calvo M, Stefani S, Schade R, Yusuf E, van Kleef-van Koeveringe S, Vandamme S, Verroken A, Rodriguez-Villalobos H, Duigou F, Corvec S, Floch P, Massip C, Chainier D, Barraud O, Louissaint M-B, Mizrahi A, Ali S, Doyle M, Egan C, McNicholas S, Colomina-Rodriguez J, Torres I, Gillaranz Luengo R, Larrosa Escartín MN, Viñado Perez MB, Halperin AV, Fuente García S, Cantón R, Seruca M, Santos Mendes V, Carvalho D, Cavallo R, [[people:​jmelocristino|Melo-Cristino J]], Costa C, Bianco G. 2025. <fc #​0000FF>​A european survey on anaerobes from paediatric blood cultures: a comparative analysis with adults</​fc>​. Eur J Clin Microbiol Infect Dis 44:​2207–2217. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​40537731/​|(PMID:​ 40537731)]]
Line 27: Line 38:
  
 Schnyder JL, de Jong HK, Bache EB, van Hest RM, Bélard S, Hanscheid T, Kremsner PG, Grobusch MP. 2025. <fc #​0000FF>​Which trial do we need? A randomised controlled study to compare the protective efficacy of early post-exposure discontinuation versus standard atovaquone-proguanil malaria prophylaxis in a human //​Plasmodium falciparum//​ challenge model</​fc>​. Clin Microbiol Infect 31:​1618–1622. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​40294866/​|(PMID:​ 40294866)]] Schnyder JL, de Jong HK, Bache EB, van Hest RM, Bélard S, Hanscheid T, Kremsner PG, Grobusch MP. 2025. <fc #​0000FF>​Which trial do we need? A randomised controlled study to compare the protective efficacy of early post-exposure discontinuation versus standard atovaquone-proguanil malaria prophylaxis in a human //​Plasmodium falciparum//​ challenge model</​fc>​. Clin Microbiol Infect 31:​1618–1622. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​40294866/​|(PMID:​ 40294866)]]
 +
 +Hänscheid T, Grobusch MP. 2025. <fc #​0000FF>​Balancing safety and efficacy: new insights on primaquine for malaria transmission blocking</​fc>​. Lancet, Infect Dis 25:​948–949. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​40286801/​|(PMID:​ 40286801)]]
  
 Boattini M, Bianco G, Bastos P, Mavromanolaki VE, Maraki S, Spiliopoulou A, Kakouris V, Kalchev Y, Budimir A, Bedenić B, Rubic Z, Licker M, Musuroi C, Juhász E, Kristóf K, Pirs M, Velimirovic I, Berktold M, Liptáková A, Krajcikova A, Drevinek P, Gryndlerova A, Brzychczy-Wloch M, Olechowska-Jarząb A, Bielec F, Brauncajs M, Podsiadly E, Nurzyńska G, Zalas-Więcek P, Riesbeck K, Andersson H-S, Tønjum T, Berild JC, Leegaard TM, Rasmussen AN, Schønning K, Glöckner S, Rödel J, Badr MT, Häcker GA, Stark D, Hamprecht A, Dudakova A, Jantsch J, Mancini S, Quiblier C, Jacot D, Greub G, Ferniani T, Ambretti S, Calvo M, Stefani S, Schade R, Yusuf E, Koeveringe S van K, Vandamme S, Verroken A, Rodriguez-Villalobos H, Duigou F, Corvec S, Floch P, Massip C, Chainier D, Barraud O, Louissaint M-B, Mizrahi A, Ali S, Doyle M, Egan C, McNicholas S, Colomina-Rodriguez J, Torres I, Luengo RG, Escartín MNL, Perez MBV, Halperin AV, García SF, Cantón R, Seruca M, Mendes VS, Carvalho D, Cavallo R, [[people:​jmelocristino|Melo-Cristino J]], Costa C. 2025. <fc #​0000FF>​Diagnostic and epidemiological landscape of anaerobic bacteria in Europe, 2020-2023 (ANAEuROBE)</​fc>​. Int J Antimicrob Agents 65:107478. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​40024606/​|(PMID:​ 40024606)]] Boattini M, Bianco G, Bastos P, Mavromanolaki VE, Maraki S, Spiliopoulou A, Kakouris V, Kalchev Y, Budimir A, Bedenić B, Rubic Z, Licker M, Musuroi C, Juhász E, Kristóf K, Pirs M, Velimirovic I, Berktold M, Liptáková A, Krajcikova A, Drevinek P, Gryndlerova A, Brzychczy-Wloch M, Olechowska-Jarząb A, Bielec F, Brauncajs M, Podsiadly E, Nurzyńska G, Zalas-Więcek P, Riesbeck K, Andersson H-S, Tønjum T, Berild JC, Leegaard TM, Rasmussen AN, Schønning K, Glöckner S, Rödel J, Badr MT, Häcker GA, Stark D, Hamprecht A, Dudakova A, Jantsch J, Mancini S, Quiblier C, Jacot D, Greub G, Ferniani T, Ambretti S, Calvo M, Stefani S, Schade R, Yusuf E, Koeveringe S van K, Vandamme S, Verroken A, Rodriguez-Villalobos H, Duigou F, Corvec S, Floch P, Massip C, Chainier D, Barraud O, Louissaint M-B, Mizrahi A, Ali S, Doyle M, Egan C, McNicholas S, Colomina-Rodriguez J, Torres I, Luengo RG, Escartín MNL, Perez MBV, Halperin AV, García SF, Cantón R, Seruca M, Mendes VS, Carvalho D, Cavallo R, [[people:​jmelocristino|Melo-Cristino J]], Costa C. 2025. <fc #​0000FF>​Diagnostic and epidemiological landscape of anaerobic bacteria in Europe, 2020-2023 (ANAEuROBE)</​fc>​. Int J Antimicrob Agents 65:107478. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​40024606/​|(PMID:​ 40024606)]]
Line 39: Line 52:
  
 Elias R, Modesto A, Machado D, Pereira B, Phelan J, [[people:​jmelocristino|Melo-Cristino J]], Lito L, Gonçalves L, Portugal I, Viveiros M, Campino S, Clark TG, Duarte A, Perdigão J. 2025. <fc #​0000FF>​Dissemination of arr-2 and arr-3 is associated with class 1 integrons in //​Klebsiella pneumoniae//​ clinical isolates from Portugal</​fc>​. Med Microbiol Immunol 214:6. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​39775075/​|(PMID:​ 39775075)]] Elias R, Modesto A, Machado D, Pereira B, Phelan J, [[people:​jmelocristino|Melo-Cristino J]], Lito L, Gonçalves L, Portugal I, Viveiros M, Campino S, Clark TG, Duarte A, Perdigão J. 2025. <fc #​0000FF>​Dissemination of arr-2 and arr-3 is associated with class 1 integrons in //​Klebsiella pneumoniae//​ clinical isolates from Portugal</​fc>​. Med Microbiol Immunol 214:6. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​39775075/​|(PMID:​ 39775075)]]
 +
 +Pereira SM, Grobusch MP, Hänscheid T. 2025. <fc #​0000FF>​How a GPT-aided survey reveals a medical student’s misunderstanding of the term “artemisinin resistance.”</​fc>​ New Microbes New Infect 63:101552. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​39759404/​|(PMID:​ 39759404)]]
 +
 +Hänscheid T, Grobusch MP. 2025. <fc #​0000FF>​Is strong artificial intelligence skepticism justified or counterproductive?</​fc>​ Clin Infect Dis: Off Publ Infect Dis Soc Am 80:​1166–1167. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​39219480/​|(PMID:​ 39219480)]]
  
 ===== 2024  ===== ===== 2024  =====
 Hänscheid T, Mahomed SM, Rebelo M, Henriques SO, Grobusch MP. 2024. <fc #​0000FF>​Inaccurate communication in health sciences: the case of “partial artemisinin resistance” for the treatment of malaria</​fc>​. New Microbes New Infect 62:101544. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​39719945/​|(PMID:​ 39719945)]] Hänscheid T, Mahomed SM, Rebelo M, Henriques SO, Grobusch MP. 2024. <fc #​0000FF>​Inaccurate communication in health sciences: the case of “partial artemisinin resistance” for the treatment of malaria</​fc>​. New Microbes New Infect 62:101544. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​39719945/​|(PMID:​ 39719945)]]
- 
-Pereira SM, Grobusch MP, Hänscheid T. 2025. <fc #​0000FF>​How a GPT-aided survey reveals a medical student’s misunderstanding of the term “artemisinin resistance.”</​fc>​ New Microbes New Infect 63:101552. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​39759404/​|(PMID:​ 39759404)]] 
  
 [[people:​jfsilva|Gomes-Silva J]], [[people:​mdpinho|Pinho MD]], [[people:​afriaes|Friães A]], [[people:​ramirez|Ramirez M]], [[people:​jmelocristino|Melo-Cristino J]], [[people:​anacosta|Silva-Costa C]], Portuguese Group for the Study of Streptococcal Infections, Portuguese Study Group of Invasive Pneumococcal Disease of the Pediatric Infectious Disease Society. 2024. <fc #​0000FF>​Pneumococci remain the main cause of complicated pediatric pneumonia in the post-pandemic era despite extensive pneumococcal vaccine use</​fc>​. Pneumonia 16:26. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​39582053/​|(PMID:​ 39582053)]] [[people:​jfsilva|Gomes-Silva J]], [[people:​mdpinho|Pinho MD]], [[people:​afriaes|Friães A]], [[people:​ramirez|Ramirez M]], [[people:​jmelocristino|Melo-Cristino J]], [[people:​anacosta|Silva-Costa C]], Portuguese Group for the Study of Streptococcal Infections, Portuguese Study Group of Invasive Pneumococcal Disease of the Pediatric Infectious Disease Society. 2024. <fc #​0000FF>​Pneumococci remain the main cause of complicated pediatric pneumonia in the post-pandemic era despite extensive pneumococcal vaccine use</​fc>​. Pneumonia 16:26. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​39582053/​|(PMID:​ 39582053)]]
Line 52: Line 67:
  
 Pool L, Ruiz Del Portal Luyten C, van der Pluijm RW, Soentjens P, Hänscheid T, Grobusch MP, Visser BJ. 2024. <fc #​0000FF>​Dissemination and outcome reporting bias in clinical malaria intervention trials: a cross-sectional analysis</​fc>​. Malar J 23:293. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​39350104/​|(PMID:​ 39350104)]] Pool L, Ruiz Del Portal Luyten C, van der Pluijm RW, Soentjens P, Hänscheid T, Grobusch MP, Visser BJ. 2024. <fc #​0000FF>​Dissemination and outcome reporting bias in clinical malaria intervention trials: a cross-sectional analysis</​fc>​. Malar J 23:293. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​39350104/​|(PMID:​ 39350104)]]
- 
-Hänscheid T, Grobusch MP. 2024. <fc #​0000FF>​Is strong AI skepticism justified or counterproductive?</​fc>​ Clin Infect Dis ciae443. //In press// [[https://​www.ncbi.nlm.nih.gov/​pubmed/​39219480/​|(PMID:​ 39219480)]] 
- 
  
 Barros Pinto MP. 2024. <fc #​0000FF>//​Bordetella pertussis// infection</​fc>​. Pediatr Pulmonol 59:​3752–3753. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​39189943/​|(PMID:​ 39189943)]] Barros Pinto MP. 2024. <fc #​0000FF>//​Bordetella pertussis// infection</​fc>​. Pediatr Pulmonol 59:​3752–3753. [[https://​www.ncbi.nlm.nih.gov/​pubmed/​39189943/​|(PMID:​ 39189943)]]
  • publications.1766411500.txt.gz
  • Last modified: 2025/12/22 14:51
  • by ramirez